ACTON, Mass. – Insulet Corporation reported revenue of $783.8 million for the fourth quarter of 2025, an increase of 31% over the same period a year prior and ahead of the company’s guidance in the 25 ...

DexCom’s fourth quarter results reflected ongoing momentum in both product innovation and international expansion. Management attributed the quarter’s performance to the broad rollout of the G7 15-day ...

With wider US clearance for type 1 and type 2 diabetes, Insulet raised its outlook and expanded buybacks after topping revenue and earnings estimates. Insulet sells a tubeless, skin-worn insulin pump ...

Insulet stock is up on fourth-quarter results ahead of consensus, with company leaders talking about talent, technology, and momentum.

ACTON, Mass. – Insulet’s Omnipod 5 Automated Insulin Delivery (AID) System is now available in the Middle East – including Saudi Arabia, Kuwait, Qatar, and the United Arab Emirates (UAE). “We’re proud ...

DexCom expects 2026 total revenue to be in a range of $5.16 billion to $5.25 billion, representing growth of 11% to 13% for the year. Sylvain indicated, "This guidance assumes continued strong ...

Feb 12 (Reuters) - Medical device maker Dexcom (DXCM.O), opens new tab beat Wall Street estimates for fourth-quarter results on Thursday, driven by robust demand for its continuous glucose monitoring ...

The UK Treasury has selected HSBC Holdings, Europe’s largest bank by assets, and Ashurst, a prominent international law firm, to lead a pilot program for digital gilt, a move that could make the UK ...

Connecting your smartphone to your Windows PC laptop or computer is a convenient way to stay organized and focused throughout your day. With a quick setup, you can reply to messages, check ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced its transformative Omnipod 5 ...